News >

Homing in on Targeted Treatment Strategies in Breast Cancer

Caroline Seymour
Published: Wednesday, Feb 19, 2020

Neelima Denduluri, MD

Neelima Denduluri, MD

The fields of early-stage hormone receptor (HR)–positive and metastatic HER2-positive breast cancer have made great strides in recent years, said Neelima Denduluri, MD, and such progress could be attributed to the emergence of tailored treatment strategies and the use of HER2-directed agents, respectively.
... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Publication Bottom Border
Border Publication